The rise of Viagra initially fueled a boom for pharma, but recent shifts present a complicated outlook for investors. Lower-cost competitors are reducing earnings, and persistent patent challenges add further https://jaysoncipu178930.dm-blog.com/41490795/viagra-and-pharma-a-volatile-bet